GE Healthcare Unveils New Applications and Smart Devices Built on “Edison” – a Next Generation Intelligence Platform
25 November 2018 - 1:00AM
Business Wire
- Expanding on GE Healthcare’s 200+
Imaging applications, Edison includes new technologies to improve
scan consistency, help clinicians detect and prioritize acute cases
and extend the lifecycle of devices
- Among the 100+ GE Healthcare developer
services on Edison is a tool that tracks the source and usage of
data in AI development, simplifying developers’ ability to create
compliant algorithms
- Edison is the most holistic and
integrated digital platform in healthcare, combining globally
diverse data sets from across modalities, vendors, healthcare
networks and life sciences settings
GE Healthcare today announced new applications and smart devices
built on Edison – a platform that helps accelerate the development
and adoption of Artificial Intelligence (AI) technology and empower
providers to deliver faster, more precise care. Edison is part of
GE Healthcare’s $1 billion and growing Digital portfolio and will
serve as a “digital thread” for its existing AI partnerships and
products. Clinical partners will use Edison to develop algorithms,
and technology partners will work with GE Healthcare to bring the
latest advancements in data processing to Edison applications and
smart devices.
The healthcare AI market will reach $6.6 billion in 2021, and 39
percent of healthcare provider executives say that they’re
investing in AI, machine learning and predictive analytics.
Appreciating the technology’s potential, GE Healthcare is
presenting the following Edison applications and Edison-powered
devices at the 104th annual meeting of the Radiological Society of
North America (RSNA).
- AIRx* is an AI-based, automated
workflow tool for MRI brain scanning designed to increase
consistency and productivity. AIRx is designed to provide
automated slice prescriptions to help reduce previously redundant,
manual steps. AIRx is intended to produce images that have
less variability between technologists and between scans, to help
lower the chances for a patient to be recalled due to incorrect
slice placement. An increase in consistency is particularly
important when doing longitudinal assessments for diseases like
Alzheimer’s and Multiple Sclerosis. AIRx features a
pre-trained neural network model that leverages deep learning
algorithms and anatomy recognition based on a database of over
36,000 images sourced from clinical studies and reference sites.
*510(k) pending at FDA. Not available for sale.
- Critical Care Suite* on
Optima XR240amx is designed to identify cases with the
critical condition of pneumothorax at the point-of-care to enable
prioritization of image review. Critical Care Suite will employ a
suite of AI algorithms, such as pneumothorax detection, designed to
identify this potentially life-threatening condition in chest
X-Rays with high accuracy (>0.95 AUC). The AI algorithms are
hosted on the mobile X-Ray system – a first of its kind AI-embedded
imaging device – designed to share the output through an onscreen
notification. When a pneumothorax condition is identified, the
point-of-care notification alerts the clinical team, enabling
prioritization of image review. The AI results are sent to PACS for
review of the critical findings by a radiologist. *510(k) pending
at FDA. Not available for sale.
- CT Smart Subscription provides
continuous access to the latest CT software, extending the
lifecycle of the device and making it more valuable over time.
Applications can be selected based on a hospital or health system’s
unique needs, with options ranging from intracranial hemorrhage and
stroke detection to routine dose reduction and optimization to
cardiac function assessment.
- Automated Lesion Segmentation on
LOGIQ™ E10 increases productivity through automation.
Ultrasound users experience significant ergonomic challenges due to
repetitive exam steps. Automated Lesion Segmentation helps
eliminate the need for the user to measure lesions manually, by
segmenting an identified breast, thyroid or liver lesion and
automatically providing a trace of the lesion and corresponding
area. This feature also helps ensure consistency among different
users, or even the same user, for documentation and
follow-ups.
“There's a lot of hidden meaning in the deep data, but it takes
a significant sophistication to extract the value,” said Dr.
Rachael Callcut, a partner in the development of Critical Care
Suite, Associate Professor of Surgery at UCSF, a surgeon at UCSF
Health and Director of Data Science for the Center for Digital
Health Innovation. “AI gives us an opportunity to see patterns that
we don't see and change the way we care for patients, which can
ultimately improve outcomes.”
Edison also offers a cutting-edge service that allows data to be
traced during the development of an algorithm. This tool, which
reflects GE Healthcare’s commitment to safe, ethical and effective
use of AI, could boost clinicians’ trust in the technology and
radically simplify a developer’s ability to create compliant AI
applications. The AI capabilities are just one of the more than 100
Edison services available to GE Healthcare and ultimately
third-party developers. Other services include security,
visualization, utilization management and auto-protocoling.
For hospital executives, the Edison platform allows GE
Healthcare to add continuous value to its millions of installed
medical devices with smart workflows. Clinicians who use Edison
applications, which were built using Edison services, can be
assured by the fact that algorithms were developed with and
validated by a best-in-class ecosystem of clinical and technology
partners. Developers who use Edison will benefit from a common
integrated platform that brings together globally diverse data from
across modalities, vendors and care settings.
“Edison provides clinicians with an integrated digital platform,
combining diverse data sets from across modalities, vendors,
healthcare networks and life sciences settings,” said Kieran
Murphy, President and CEO of GE Healthcare. “Applications built on
Edison will include the latest data processing technologies to
enable clinicians to make faster, more informed decisions to
improve patient outcomes.”
Edison applications can be deployed on medical devices, via the
cloud or on the edge (computing technology that sits close to the
physical device).
GE Healthcare is showcasing its Edison applications and
Edison-powered devices at RSNA in the North Hall, Booth 7334. The
full GE Healthcare RSNA 2018 press kit can be found here.
About GE Healthcare
GE Healthcare is the $19 billion healthcare business of GE
(NYSE: GE). As a leading provider of medical imaging, monitoring,
biomanufacturing, and cell and gene therapy technologies, GE
Healthcare enables precision health in diagnostics, therapeutics
and monitoring through intelligent devices, data analytics,
applications and services. With over 100 years of experience in the
healthcare industry and more than 50,000 employees globally, the
company helps improve outcomes more efficiently for patients,
healthcare providers, researchers and life sciences companies
around the world. Follow us on Facebook, LinkedIn, Twitter or The
Pulse for the latest news, or visit our website
www.gehealthcare.com for more information.
Certain statements in this press release are forward-looking.
Any descriptions of future functionality reflect current product
direction, are for informational purposes only, and do not
constitute a commitment to provide specific functionality. Timing
and availability are subject to change and applicable regulatory
approvals.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181124005002/en/
GE Healthcare Media ContactKelley
SousaKelley.Sousa@ge.com+1 312-288-1249
GE Aerospace (NYSE:GE)
Historical Stock Chart
From May 2024 to Jun 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Jun 2023 to Jun 2024